87 related articles for article (PubMed ID: 15834298)
1. Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; Neaton JD; Grimm RH; Hansson L; Lacourcière Y; Muller JE; Sleight P; Weber MA; White WB; Williams GH; Wittes J; Zanchetti A; Anders RJ;
J Hypertens; 2005 May; 23(5):1099-106. PubMed ID: 15834298
[TBL] [Abstract][Full Text] [Related]
2. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.
Black HR; Elliott WJ; Neaton JD; Grandits G; Grambsch P; Grimm RH; Hansson L; Lacoucière Y; Muller J; Sleight P; Weber MA; White WB; Williams G; Wittes J; Zanchetti A; Fakouhi TD
Control Clin Trials; 1998 Aug; 19(4):370-90. PubMed ID: 9683312
[TBL] [Abstract][Full Text] [Related]
4. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
5. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P
J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
[TBL] [Abstract][Full Text] [Related]
9. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.
Liu L; Zhang Y; Liu G; Li W; Zhang X; Zanchetti A;
J Hypertens; 2005 Dec; 23(12):2157-72. PubMed ID: 16269957
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
de Leeuw PW; Notter T; Zilles P
J Hypertens; 1997 Jan; 15(1):87-91. PubMed ID: 9050975
[TBL] [Abstract][Full Text] [Related]
11. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
[TBL] [Abstract][Full Text] [Related]
12. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
[TBL] [Abstract][Full Text] [Related]
13. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861
[TBL] [Abstract][Full Text] [Related]
14. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
[TBL] [Abstract][Full Text] [Related]
15. Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group.
Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S33-7. PubMed ID: 1725915
[TBL] [Abstract][Full Text] [Related]
16. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
[TBL] [Abstract][Full Text] [Related]
17. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
18. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Messerli FH; Mancia G; Conti CR; Hewkin AC; Kupfer S; Champion A; Kolloch R; Benetos A; Pepine CJ
Ann Intern Med; 2006 Jun; 144(12):884-93. PubMed ID: 16785477
[TBL] [Abstract][Full Text] [Related]
19. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
[TBL] [Abstract][Full Text] [Related]
20. Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.
Black HR; Elliott WJ; Neaton JD; Grandits G; Grambsch P; Grimm RH; Hansson L; Lacoucière Y; Muller J; Sleight P; Weber MA; White WB; Williams G; Wittes J; Zanchetti A; Fakouhi TD; Anders RJ
Hypertension; 2001 Jan; 37(1):12-18. PubMed ID: 11208750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
